About The Study: In this randomized clinical trial, among adults with long COVID, colchicine did not improve functional capacity, respiratory function, or inflammatory markers. These findings ...
Nov 27 (Reuters) - Colchicine, a commonly used anti-inflammatory drug, will be investigated as a possible treatment for COVID-19 in the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial, the ...
The Covid-19 pandemic has been perceived mainly as a dangerous acute outbreak of infection that killed more than a million people in the United States and 7 million worldwide. 1,2 However, in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results